Evidence map›Paper›PMID 40192915›Full record

ArticleJournal of fluorescence2025

Dual-Quenching Mechanism-Based Fluorometric Sensing Platform for Precise D-Penicillamine Quantification in Therapeutic Drug Monitoring.

Yousef A Bin Jardan, Mohamed M El-Wekil, Aya M Mostafa, James Barker, Al-Montaser Bellah H Ali

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Fluorescence quenching-based methods for pharmaceutical analysis: a comprehensive review of principles, probes, and applications.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yousef A Bin JardanDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.
Mohamed M El-WekilDepartment of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt.
Aya M MostafaDepartment of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt.
James BarkerSchool of Life Sciences, Pharmacy, and Chemistry, Kingston University, Kingston-upon- Thames, London, KT1 2EE, UK.
Al-Montaser Bellah H AliDepartment of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt. Almontaser_bellah@aun.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel, highly sensitive fluorometric method for D-penicillamine (D-PA) detection has been developed, addressing critical needs in therapeutic drug monitoring. D-PA, a crucial chelating agent used in treating Wilson's disease, rheumatoid arthritis, and heavy metal poisoning, requires precise quantification due to its narrow therapeutic window and potential toxicity. The proposed method introduces an innovative sensing platform utilizing red-emissive carbon dots (R@CDs) and cobalt ions, which enables exceptional analytical performance through a sophisticated dual-quenching mechanism. The detection strategy involves cobalt ions initially enhancing the fluorescence of R@CDs. Upon D-PA addition, two synergistic quenching effects occur: competitive displacement of cobalt ions from the carbon dot surface and formation of a yellow-colored D-PA-cobalt complex, inducing an inner filter effect. Comprehensive characterization and mechanistic investigation revealed the intricate molecular interactions governing this detection process. The developed method demonstrated excellent analytical performance, exhibiting excellent linearity (R

Indexed as

Drug MonitoringFluorometryPenicillamineAnimalsCarbonCobaltMaleQuantum DotsRatsSpectrometry, FluorescenceCarbonCobaltPenicillamine

Identifiers

PMID40192915

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.